Ocugen Statistics
Share Statistics
Ocugen has 291.32M shares outstanding. The number of shares has increased by 13.57% in one year.
| Shares Outstanding | 291.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.2% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 286.08M |
| Failed to Deliver (FTD) Shares | 18 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 58.63M, so 20.13% of the outstanding shares have been sold short.
| Short Interest | 58.63M |
| Short % of Shares Out | 20.13% |
| Short % of Float | 20.42% |
| Short Ratio (days to cover) | 14.91 |
Valuation Ratios
The PE ratio is -2.23 and the forward PE ratio is -3.92.
| PE Ratio | -2.23 |
| Forward PE | -3.92 |
| PS Ratio | 23.28 |
| Forward PS | 10.4 |
| PB Ratio | 3.46 |
| P/FCF Ratio | -1.94 |
| PEG Ratio | n/a |
Enterprise Valuation
Ocugen Inc. has an Enterprise Value (EV) of 107.97M.
| EV / Earnings | -1.71 |
| EV / Sales | 17.89 |
| EV / EBITDA | -1.67 |
| EV / EBIT | -1.65 |
| EV / FCF | -1.49 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.51 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.09 |
| Total Debt / Capitalization | 8.39 |
| Cash Flow / Debt | -16.7 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.56% and return on capital (ROIC) is -137.95%.
| Return on Equity (ROE) | -1.56% |
| Return on Assets (ROA) | -0.98% |
| Return on Capital (ROIC) | -137.95% |
| Revenue Per Employee | 92.86K |
| Profits Per Employee | -970.43K |
| Employee Count | 65 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 30.33% in the last 52 weeks. The beta is 3.77, so Ocugen 's price volatility has been higher than the market average.
| Beta | 3.77 |
| 52-Week Price Change | 30.33% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 37.08 |
| Average Volume (20 Days) | 4.59M |
Income Statement
In the last 12 months, Ocugen had revenue of 6.04M and earned -63.08M in profits. Earnings per share was -0.26.
| Revenue | 6.04M |
| Gross Profit | 5.33M |
| Operating Income | -65.53M |
| Net Income | -63.08M |
| EBITDA | -64.83M |
| EBIT | -65.53M |
| Earnings Per Share (EPS) | -0.26 |
Balance Sheet
The company has 39.46M in cash and 6.94M in debt, giving a net cash position of 32.52M.
| Cash & Cash Equivalents | 39.46M |
| Total Debt | 6.94M |
| Net Cash | 32.52M |
| Retained Earnings | -286.17M |
| Total Assets | 61.94M |
| Working Capital | 24.91M |
Cash Flow
In the last 12 months, operating cash flow was -62.05M and capital expenditures -10.48M, giving a free cash flow of -72.53M.
| Operating Cash Flow | -62.05M |
| Capital Expenditures | -10.48M |
| Free Cash Flow | -72.53M |
| FCF Per Share | -0.3 |
Margins
Gross margin is 88.34%, with operating and profit margins of -1.09K% and -1.05K%.
| Gross Margin | 88.34% |
| Operating Margin | -1.09K% |
| Pretax Margin | -1.05K% |
| Profit Margin | -1.05K% |
| EBITDA Margin | -1.07K% |
| EBIT Margin | -1.09K% |
| FCF Margin | -1.20K% |
Dividends & Yields
OCGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -35.62% |
| FCF Yield | -34.06% |
Analyst Forecast
The average price target for OCGN is $6, which is 721.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 721.9% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Sep 30, 2019. It was a backward split with a ratio of 1:60.
| Last Split Date | Sep 30, 2019 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -2.04 |
| Piotroski F-Score | 3 |